In joint statement the companies said under the terms of the proposed transaction , the businesses of Pfizer and Allergan will be combined under Allergan plc , which will be renamed " Pfizer plc . " The companies expect that shares of the combined company will be listed on the New York Stock Exchange and trade under the " PFE " ticker . Upon the closing of the transaction , the combined company is expected to maintain Allergan ' s Irish legal domicile . Pfizer plc will have its global operational headquarters in New York and its principal executive offices in Ireland .
